Abstract
Gliomas are the most frequent and malignant brain tumors among the central nervous system neoplasms. Among glial types, glioblastomas (GBMs) are incurable, with an average survival of approximately 13 months, and less than 2% of patients reach 5 years after treatment. The low success rate in these tumors is due in part to the low understanding of their molecular basis. In 2016 our researc…